Correlation Between Medical Developments and Centaurus Metals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medical Developments and Centaurus Metals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medical Developments and Centaurus Metals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medical Developments International and Centaurus Metals, you can compare the effects of market volatilities on Medical Developments and Centaurus Metals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medical Developments with a short position of Centaurus Metals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medical Developments and Centaurus Metals.

Diversification Opportunities for Medical Developments and Centaurus Metals

0.3
  Correlation Coefficient

Weak diversification

The 3 months correlation between Medical and Centaurus is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Medical Developments Internati and Centaurus Metals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centaurus Metals and Medical Developments is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medical Developments International are associated (or correlated) with Centaurus Metals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centaurus Metals has no effect on the direction of Medical Developments i.e., Medical Developments and Centaurus Metals go up and down completely randomly.

Pair Corralation between Medical Developments and Centaurus Metals

Assuming the 90 days trading horizon Medical Developments International is expected to under-perform the Centaurus Metals. But the stock apears to be less risky and, when comparing its historical volatility, Medical Developments International is 1.27 times less risky than Centaurus Metals. The stock trades about -0.04 of its potential returns per unit of risk. The Centaurus Metals is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  46.00  in Centaurus Metals on September 14, 2024 and sell it today you would lose (6.00) from holding Centaurus Metals or give up 13.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medical Developments Internati  vs.  Centaurus Metals

 Performance 
       Timeline  
Medical Developments 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medical Developments International has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Centaurus Metals 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Centaurus Metals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable primary indicators, Centaurus Metals is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Medical Developments and Centaurus Metals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medical Developments and Centaurus Metals

The main advantage of trading using opposite Medical Developments and Centaurus Metals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medical Developments position performs unexpectedly, Centaurus Metals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centaurus Metals will offset losses from the drop in Centaurus Metals' long position.
The idea behind Medical Developments International and Centaurus Metals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance